NCT06121843

arlo-cel-shows-promise-in-treating-relapsed-myeloma-patients

Arlo-cel Shows Promise in Treating Relapsed Myeloma Patients

Editorial 22 October, 2025

The novel GPRC5D-targeted CAR T-cell therapy, known as arlocabtagene autoleucel (arlo-cel), has demonstrated significant...

arlo-cel-shows-promise-as-key-therapy-for-multiple-myeloma

Arlo-Cel Shows Promise as Key Therapy for Multiple Myeloma

Editorial 22 October, 2025

The experimental CAR T-cell therapy, arlocabtagene autoleucel (arlo-cel), may provide a significant treatment option...